SEED Innovations Portfolio Company Juvenescence Raises $76M to Advance Longevity Therapies

SEED Innovations Limited (LSE:SEED) has announced a major milestone for its portfolio, with Juvenescence securing $76 million in the initial close of its Series B-1 funding round. The investment was led by M42, a prominent healthcare company based in Abu Dhabi. This fresh capital will be used to accelerate Juvenescence’s pipeline of AI-driven therapeutics aimed at prolonging healthy lifespan and treating serious diseases.

The funding marks a significant step forward for Juvenescence, with further clinical developments expected in the near future. The deal reinforces SEED Innovations’ strategy of backing cutting-edge, high-growth ventures in the health and technology sectors.

About SEED Innovations Limited

SEED Innovations Ltd is an AIM-listed investment firm focused on identifying and supporting disruptive companies in the life sciences and tech industries. The company provides retail investors with access to early-stage, high-potential opportunities that are typically reserved for institutional or private capital.

• Average Daily Trading Volume: 480,301 shares

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Comments are closed

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  Dan Atkinson

• 

  Francois Normandeau

• 

  John Piper

• 

  Jessica K